FLUIMEDIX ApS
CVR 27021689 · Private limited company (ApS) · Active · Low risk
FLUIMEDIX ApS is a Private limited company (ApS), founded on , based in Frederiksberg. The company is registered in the industry anden teknisk rådgivning. Our model estimates a bankruptcy risk of 0.5% over the next 12 months, which is 0.4 times the average for Danish companies. 20 annual reports have been published, of which 6 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 256k and a net result of DKK 18k. CEO: Tomas Ussing.
Bankruptcy risk for FLUIMEDIX ApS
0.4 × the average (1.41%) · higher risk than 60% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 27021689
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (23 years)
- Address
- Dalgas Boulevard 4
2000 Frederiksberg - Municipality
- Frederiksberg
- Industry
- Anden teknisk rådgivning (711290)
Bankruptcies in the industry: Rådgivende ingeniørvirksomhed inden for byggeri og anlægsarbejder - Share capital
- DKK 778k
- Employees
- 5 (2018)
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 6 of 23 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 77.7% |
| Current ratio | 448% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 2 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 12k | DKK -56k |
| Net profit | DKK 18k | DKK -65k |
| Equity | DKK 256k | DKK 238k |
| Total assets | DKK 329k | DKK 324k |
| Cash | DKK 165k | – |
| Short-term debt | DKK 73k | – |
| Avg. employees | 1 | – |
Latest annual report: Reporting class B · auditor's statement: No assurance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 180 | ||
| 1 Jan 2024 – 31 Dec 2024 | 189 | Late | |
| 1 Jan 2023 – 31 Dec 2023 | 159 | ||
| 1 Jan 2022 – 31 Dec 2022 | 193 | Late | |
| 1 Jan 2021 – 31 Dec 2021 | 193 | Late | |
| 1 Jan 2020 – 31 Dec 2020 | 193 | Late | |
| 1 Jan 2019 – 31 Dec 2019 | 239 | Late | |
| 1 Jan 2018 – 31 Dec 2018 | 141 | ||
| 1 Jan 2017 – 31 Dec 2017 | 162 | ||
| 1 Jan 2016 – 31 Dec 2016 | 151 | ||
| 1 Jan 2015 – 31 Dec 2015 | 153 | ||
| 1 Jan 2014 – 31 Dec 2014 | 154 | ||
| 1 Jan 2013 – 31 Dec 2013 | 155 | ||
| 1 Jan 2012 – 31 Dec 2012 | 155 | ||
| 1 Jan 2011 – 31 Dec 2011 | 185 | Late | |
| 1 Jan 2010 – 31 Dec 2010 | 173 | ||
| 1 Jan 2009 – 31 Dec 2009 | 179 | ||
| 1 Jan 2008 – 31 Dec 2008 | 159 | ||
| 1 Jan 2007 – 31 Dec 2007 | 172 | ||
| 1 Jan 2006 – 31 Dec 2006 | 182 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Tomas Ussing | Current | |
| Board | Tomas Ussing | Current | |
| Board | Rolf Bertil Ehrnström | Current | |
| Board | Rolf Singer | Current | |
| Board | Steen Hansen | Current | |
| Board | Sissel Mygind Trap | Current | |
| Board | Niels Meidahl | ||
| Board | Mikael Ørum | ||
| Board | Tom Olesen | ||
| Board | Ole Bitsch-Jensen | ||
| Board | Per Ove Öhman | ||
| Board | Richard Gustav Bunck | ||
| Board | Tonni Bülow-Nielsen | ||
| Owner (100%) | OPFINDER HOLDING AF 2003 ApS | Current | |
| Owner (25%) | OPFINDER HOLDING AF 2003 ApS | ||
| Owner (67%) | BAUNEGÅRD ApS | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Auditor | BDO Holding VII, statsautoriseret revisionsaktieselskab | ||
| Founder | OPFINDER HOLDING AF 2003 ApS | Current |
The CEOs' other companies
Tomas Ussing – 3 other companies
- IDTA ApS Active
- OPFINDER HOLDING AF 2003 ApS Active
- RB ApS Opløst
Address history (5 moves)
| Dalgas Boulevard 4, 2000 Frederiksberg | |
| Naverland 7, 2600 Glostrup | |
| Trekronergade 17, 2500 Valby | |
| Gregersensvej 6, 2630 Taastrup | |
| c/o Teknologisk Institut, Gregersensvej 1, 2630 Taastrup | |
| Nørrebrogade 148, 2200 København N |
Former names
| FLUIMEDIX ApS | – now |
| MEMSFLOW ApS | – |
Employees per year
Other companies at the same address
- IDTA ApS Active
- OPFINDER HOLDING AF 2003 ApS Active
Similar companies in Frederiksberg
- Aktuel ByggeRådgivning af 1980 ApS Frederiksberg C
- Inflection Pharma Consulting ApS Frederiksberg
- Trophic Aps Frederiksberg
- Energy-Watch Danmark ApS Frederiksberg C
- ARKP ApS Frederiksberg
- GreenSpin Partners ApS Frederiksberg C
- SZL Consult ApS Frederiksberg
- TJ-TECH ApS Frederiksberg
- Prezio ApS Frederiksberg C
- Optisol ApS Frederiksberg
- Frederiksberg Syn & Skøn ApS Frederiksberg C
- AngElle Bioengineering ApS Frederiksberg
Questions and answers about FLUIMEDIX ApS
Has FLUIMEDIX ApS gone bankrupt?
No, FLUIMEDIX ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of FLUIMEDIX ApS?
Our model estimates a bankruptcy risk of 0.5% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.
Who is the CEO of FLUIMEDIX ApS?
Tomas Ussing is the CEO of FLUIMEDIX ApS.
When was FLUIMEDIX ApS founded?
FLUIMEDIX ApS was founded on 6 February 2003.
What is the equity of FLUIMEDIX ApS?
Equity was DKK 256k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.